HYPE has declined 3.3% in 24 hours to $45.13 despite Hyperliquid platform recording historic $18.99 billion daily perpetuals ...

Hanoi is implementing a series of breakthrough plans, ranging from attracting investment and developing high-tech products to ...

Biopharma stock Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring today, up 20.6% at $22.17 at last glance. The ...

In July 2025, global markets have been navigating a complex landscape marked by new U.S. tariff announcements and mixed economic signals, with the Nasdaq Composite Index showing resilience amidst ...

These are two ASX favourites to watch closely this month. The post Will these ASX 100 shares surge or sink in July? appeared first on The Motley Fool Australia.

Q2 2025 saw a moderation of the inflation and growth concerns, and the 2-year EPS outlook for both large and small caps ...

In a recent market update, Goldman Sachs raised its year-end forecast for the S&P 500 (SPX) to 6,900 by year-end, up from a ...

On Tuesday, 150 stocks reached 52-week highs while 36 hit lows, as the Sensex rose over 317 points. Key sectors driving ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Meanwhile, if you buy the shares while they're down, you will have gotten in on the stock for a bargain -- and can maximize ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...